Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Additional approvals for daclatasvir and asunaprevir in Japan

March 23, 2015

Actelion presents new antimalarials

March 20, 2015

Yisheng Biopharma confirms new vaccine for rabies infection will enter human trials

March 20, 2015

Case report of emergency postexposure vaccination with VSVdeltaG-ZEBOV

March 19, 2015

Emergent manufactures MVA EBOZ Ebola vaccine candidate under new agreements

March 19, 2015

Symbiomix's antibacterial drug candidate is safe and well tolerated

March 18, 2015

Lakewood-Amedex and University of Jyvaskyla to test bisphosphocins for Borrelia burgdorferi

March 18, 2015

Galapagos introduces a new branimycin derivative DNA polymerase III inhibitor

March 18, 2015

ACH-3422 shows low potential for mitochondrial toxicity

March 17, 2015

St. Jude Children's Research Hospital patents endopeptidase Clp activators

March 16, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...